TGF-beta: problems and prospects - PubMed (original) (raw)

Review

TGF-beta: problems and prospects

M B Sporn et al. Cell Regul. 1990 Nov.

Abstract

TGF-beta research is proceeding at an exponential pace. Studies in this area have become increasingly relevant to many areas of cell regulation, continually providing new surprises and findings. One may confidently predict that TGF-beta will be one of the key molecules in future attempts to establish an integrated view of the processes whereby cells coordinate their own and mutual functions. We have seen only the beginning, and this minireview is only a glimpse.

PubMed Disclaimer

Similar articles

• Meeting report: signaling schemes for TGF-beta.
  Roberts AB, Derynck R. Roberts AB, et al. Sci STKE. 2001 Dec 18;2001(113):pe43. doi: 10.1126/stke.2001.113.pe43. Sci STKE. 2001. PMID: 11752631
• How cells read TGF-beta signals.
  Massagué J. Massagué J. Nat Rev Mol Cell Biol. 2000 Dec;1(3):169-78. doi: 10.1038/35043051. Nat Rev Mol Cell Biol. 2000. PMID: 11252892 Review.
• [Function, molecular structure and gene expression regulation of transforming growth factor-beta (TGF-beta)].
  Yamaguchi Y. Yamaguchi Y. Nihon Rinsho. 1992 Aug;50(8):1932-8. Nihon Rinsho. 1992. PMID: 1433985 Review. Japanese.
• The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.
  Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. Mishra L, et al. Oncogene. 2005 Aug 29;24(37):5775-89. doi: 10.1038/sj.onc.1208924. Oncogene. 2005. PMID: 16123810 Review.
• Negative regulation of cell growth by TGF beta.
  Polyak K. Polyak K. Biochim Biophys Acta. 1996 Mar 18;1242(3):185-99. doi: 10.1016/0304-419x(95)00009-5. Biochim Biophys Acta. 1996. PMID: 8603072 Review. No abstract available.

Cited by

• A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma.
  Craig O, Lee S, Pilcher C, Saoud R, Abdirahman S, Salazar C, Williams N, Ascher DB, Vary R, Luu J, Cowley KJ, Ramm S, Li MX, Thio N, Li J, Semple T, Simpson KJ, Gorringe KL, Holien JK. Craig O, et al. NAR Genom Bioinform. 2024 Aug 24;6(3):lqae096. doi: 10.1093/nargab/lqae096. eCollection 2024 Sep. NAR Genom Bioinform. 2024. PMID: 39184376 Free PMC article.
• MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.
  Wang L, Liu D, Wei J, Yuan L, Zhao S, Huang Y, Ma J, Yang Z. Wang L, et al. Pathol Oncol Res. 2021 Apr 29;27:1609761. doi: 10.3389/pore.2021.1609761. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257616 Free PMC article. Retracted.
• TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases.
  Totzke J, Scarneo SA, Yang KW, Haystead TAJ. Totzke J, et al. Open Biol. 2020 Sep;10(9):200099. doi: 10.1098/rsob.200099. Epub 2020 Sep 2. Open Biol. 2020. PMID: 32873150 Free PMC article. Review.
• Laser-activated transforming growth factor-β1 induces human β-defensin 2: implications for laser therapies for periodontitis and peri-implantitis.
  Tang E, Khan I, Andreana S, Arany PR. Tang E, et al. J Periodontal Res. 2017 Jun;52(3):360-367. doi: 10.1111/jre.12399. Epub 2016 Jul 11. J Periodontal Res. 2017. PMID: 27396269 Free PMC article.
• Delineating the prime mover action of progesterone for endometrial receptivity in primates.
  Ghosh D, Sengupta J. Ghosh D, et al. Indian J Med Res. 2014 Nov;140 Suppl(Suppl 1):S130-6. Indian J Med Res. 2014. PMID: 25673534 Free PMC article. Review.

References

1. 1. Immunol Ser. 1990;51:217-43 - PubMed
2. 1. Cell Regul. 1989 Nov;1(1):87-97 - PubMed
3. 1. Biochem Biophys Res Commun. 1986 Jul 16;138(1):476-82 - PubMed
4. 1. Nature. 1986 Dec 18-31;324(6098):615-7 - PubMed
5. 1. Cell. 1987 Feb 13;48(3):409-15 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database